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Abstract
Background: Medication side effects are an important cause of morbidity, mortality and costs in older people. The aim 
of our study was to examine prevalence and risk factors for self-reported medication side effects in an older cohort 
living independently in the community.
Methods: The Melbourne Longitudinal Study on Healthy Ageing (MELSHA), collected information on those aged 65 
years or older living independently in the community and commenced in 1994. Data on medication side effects was 
collected from the baseline cohort (n = 1000) in face-to-face baseline interviews in 1994 and analysed as cross-
sectional data. Risk factors examined were: socio-demographics, health status and medical conditions; medication use 
and health service factors. Analysis included univariate logistic regression to estimate unadjusted risk and multivariate 
logistic regression analysis to assess confounding and estimate adjusted risk.
Results: Self-reported medication side effects were reported by approximately 6.7% (67/1000) of the entire baseline 
MELSHA cohort, and by 8.5% (65/761) of those on medication. Identified risk factors were increased education level, 
co-morbidities and health service factors including recency of visiting the pharmacist, attending younger doctors, and 
their doctor's awareness of their medications. The greatest increase in risk for medication side effects was associated 
with liver problems and their doctor's awareness of their medications. Aging and gender were not risk factors.
Conclusion: Prevalence of self-reported medication side effects was comparable with that reported in adults 
attending General Practices in a primary care setting in Australia. The prevalence and identified risk factors provide 
further insight and opportunity to develop strategies to address the problem of medication side effects in older people 
living independently in the community setting.
Background
Medication side effects also referred to as adverse drug
reactions (ADRs) and/or adverse drug events (ADEs) are
potentially associated with all medications and include
side effects listed in product information, as well as medi-
cation-related side effects due to interactions, non-com-
pliance [1,2], prescribing errors [3] and allergic reactions
[4]. Medication side effects are an important cause of
morbidity, mortality, costs [5-16], and dissatisfaction with
care [16].
Prevalence of medication side effects depends on the
surveillance system and setting [17]. Surveillance systems
vary in case definitions, case finding, and the duration of
monitoring [14]. Mostly, medication side effects have
been examined in inpatient hospital settings and to a
lesser extent in hospital outpatient or ambulatory clinic
settings by chart review and self report. Information on
medication side effects in the community is more limited
and is mostly provided by national surveillance systems
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data.
Similarly, potential risk factors for medication side
effects have been examined mostly in hospital inpatient
or outpatient or ambulatory clinic settings. The most
consistently identified risk factors include older age,
female gender, increasing number of medications, and
increasing number of medical conditions/co-morbidities
as well as specific co-morbidities [13,14,16,18]. Other risk
factors include those related to compliance, comprehen-
sion and general patient knowledge, types of medications
(in hospital settings such medications include antibiotics,
anti-coagulants, digoxin, diuretics, hypoglycaemic,
NSAIDs, chemotherapeutics, other cardiovascular medi-
cations and analgesics), hospitalisations, medical knowl-
edge, multiple treating doctors, and multiple filling
pharmacies [18-20].
Data from the 1994 Melbourne Longitudinal Study on
Healthy Ageing (MELSHA) baseline cohort, offers a
unique opportunity to examine prevalence and risk fac-
tors for self-reported medication side effects in an older
cohort aged 65 years and over living independently in the
community.
Methods
Study Design
The Melbourne Longitudinal Study on Healthy Ageing
(MELSHA) is a prospective cohort study initiated in
1994. A cross sectional analysis was conducted on data
collected at baseline in 1994. MELSHA was approved by
the Human Ethics Committees of Latrobe University and
Melbourne University.
Study Population
The baseline MELSHA cohort, also known as the Health
Status of Older People (HSOP) was comprised of a ran-
domly selected community sample of 1000 English-
speaking persons aged 65 years and over living indepen-
dently in metropolitan Melbourne in 1994 [21,22]. A rep-
resentative sample was randomly selected from 40
Melbourne postcodes using the electoral role (voting is
compulsory for all Australian citizens between the ages of
18 and 70, and the names of all adults are maintained on
the rolls, regardless of age) [22,23]. It is estimated that
95% of Australians over 80 years are on electoral role [23].
Those eligible comprised residents of private dwellings in
metropolitan Melbourne. Potential participants were
assessed by trained researchers by phone interview and
face to face interview. Those excluded were those who
lived in non-private accommodation such as nursing
homes, hostels or hospitals (3.3%) or no longer living in
metropolitan Melbourne (1.7%); those who could not be
readily interviewed including those who did not speak
basic English (11-12%), were cognitively impaired, were
severely ill or had significant health problems (3-3.7%),
were deceased (2.0%), or were deaf; and those with an
incorrect date of birth (0.2%) [22,23]. Of the 1865 poten-
tially eligible participants identified from the electoral
role, 1422 were eligible [23]. Of those eligible 1000 partic-
ipated, a response rate of approximately 70% [22,23].
Comparisons with the Census found that the sample was
representative of older people in the Melbourne commu-
nity with the exception of those too ill to be interviewed
and non-English speaking people and that there was
over-representation of home owners and those not rely-
ing on the pension as their main source of income [21,23].
Data collection
Data were collected by questionnaire administered by
face-face interview in participants' homes on a rolling
basis from May to December 1994 [21-23]. Trained
researchers interviewed participants using the HSOP
questionnaire [21,22] and obtained self-reported answers
to a wide range of demographic and social questions as
well as details about active disease states, functional abil-
ity, and attitudes to health. There was verification of some
self-reports by interviewer observation. A brief physical
examination including height and weight and check of
eye sight and hearing completed the interview [21,22].
Results presented in this paper are based only on data
from the face to face interviews and survey. An extract of
those questions used has been included as an Appendix.
Risk factors: Exposures & Confounders
Socio-demographic factors included gender, age, marital
status, education, and country of birth [21-23]. Age was
collected as a continuous variable and then grouped as
65-74 and 75+ years. Country of birth was collected as
categorical data including Australia, Great Britain or Ire-
land, Italy, Greece or Cyprus, Yugoslavia, Germany, Neth-
erlands, New Zealand, Poland, South East Asia, Other
European, and Other; and then classified as Australian
and other. Education was measured as the highest
attained education qualification and was collected as cat-
egorical data including Bachelor degree or higher, Trade
or apprenticeship, Certificate or diploma and other; and
then grouped as those with significant high school or fur-
ther education and other. Marital status was collected as
categorical variable including now married, living with a
partner, widowed, divorced, separated, never been mar-
ried and other; and then further classified as married or
living with partner; or other (including widowed,
divorced, separated, never been married).
Health related variables included, self-rated health a
categorical variable scaled as excellent, very good, good,
fair and poor; then collapsed as poor to fair, good and
very good to excellent. Self reported use of hearing aids
or glasses were measured as present or absent and were
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the use of glasses or contacts and use of hearing aid. Self
reported medical conditions were measured by use of the
Health Retirement Survey (HRS) format and a modified
form of the Established Populations for Epidemiologic
Studies of the Elderly (EPESE) and measured as present
or absent [23]. The HRS asked if "the doctor has ever told
you that you had [name of condition]" for blood pressure,
heart attack or myocardial infarct, other heart problems
including angina and heart failure, stroke, osteoporosis or
brittle bones, and emotional, nervous or psychiatric
problems. With the EPESE participants were shown a list
of medical conditions and asked to indicate which condi-
tions they had at the time including high cholesterol, low
blood pressure, gout, diabetes or high blood sugar,
osteoarthritis (arthritis unspecified), other types of
arthritis ( including rheumatoid and other specified
types), intestinal problems (such as ulcer or hernia),
chronic bronchitis, emphysema, asthma, problems with
feet and legs, cataracts, glaucoma, liver trouble or jaun-
dice, kidney or bladder problems, anaemia, Parkinson's
disease, migraine, eczema or dermatitis or psoriasis, skin
cancer, other growths or cancer, varicose veins, thyroid
disease, and any other condition [23]. There was no infor-
mation collected from medical records or charts and no
classification using the ICD system.
Health service factors included recency of visits to the
General Practitioner (GP), pharmacist and checks of
vision, hearing, and blood pressure classified as within a
month, 1-5 months, 6-11months, 1-2 years, 3-4 years, 5
or more years, never. These were further grouped for vis-
its to GP in the last month or more than a month ago; for
visits and advice from the (chemist) pharmacy in the last
5 months or more than 5 months ago; checks of vision
within the last 12 months, hearing within 5 years, and
blood pressure within 1 month; and any hospital admis-
sions in the last 12 months, recorded as Yes or No. Their
doctor's gender and age was based on participant assess-
ment and report of their doctor's age, and doctor's age
was then grouped as younger or older than 50 years.
Medication use was based on self report of prescribed
medications that had been taken or were supposed to
have been taken in the 2 weeks preceding interview and
recorded as Yes or No. There was no information avail-
able about the types of medications. The interviewer ver-
ified and checked medication containers and packaging
that the participant had taken in the 2 week period prior
to interview. Awareness of their usual doctor (General
Practitioner (GP)) of their medications was based on par-
ticipant assessment and report and was recorded as Yes
or No. Use of strategies to assist in taking their medica-
tions was based on participant report and was recorded
as Yes or No.
Outcomes
The outcome of interest was self-reported medication
side effects ever up until the time of interview in 1994,
and was recorded as Yes or No. There was no information
collected about the severity or type of medication side
effects.
Data Analysis
Data analysis was conducted on the whole cohort (n =
1000) to capture those who may have ceased taking medi-
cation due to side effects and on those currently taking at
least one prescribed medication (n = 761). Preliminary
analysis using chi square analyses tested direct relation-
ships between independent variables (possible risk fac-
tors) and the dependent (outcome variable) of self-
reported medication side effects. The association
between existing risk factors including sociodemograph-
ics, health status and medical conditions, health service
use and medication use and self-reported medication side
effects was examined using logistic regression analysis.
Univariate logistic regression was used to calculate crude
odds ratios (OR) with 95% confidence intervals. Multivar-
iate logistic regression analysis was used to calculate
adjusted OR with 95% confidence intervals (95%CI). Fac-
tors achieving statistical significance at the bi-variate
level (p < 0.20)in the univariate analysis, and/or docu-
mented in the literature or with plausible biological
mechanisms were included in the multiple logistic regres-
sion model and included those risk factors described pre-
viously in the methods. Multi-collinearity was assessed
by checking the partial correlation matrix of all factors
introduced to the model. SPSS (version 17) was used for
all statistical analysis.
Results
Sociodemographics
The baseline MELSHA cohort was predominantly aged
65 to 74 years, married, lacking in education and Austra-
lian born. There were similar numbers of males and
females. See Table 1
Health Status and Medical conditions
The baseline MELSHA cohort reported mostly good to
excellent health. The most common self reported medical
conditions included: osteoarthritis (51%), hypertension
(43%), problems with feet or legs (36%), varicose veins
(21%), intestinal problems (20%), other heart problems
(20%), cataracts (19%), kidney or bladder problems (12%),
high cholesterol (12%), skin problems (including eczema,
dermatitis and psoriasis) (11%), skin cancer (11%) and
emotional or psychiatric problems (9%). See Table 1. Fur-
thermore, 15% of the cohort reported using a hearing aid
and 96% reported wearing glasses.
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Table 1: Socio-demographics, self reported health and medical conditions
n % *N
Sociodemographics 
Age (years) 65 - 74 642 64 1000
75+ 358 36
Gender Male 467 47 1000
Country of Birth Born in Australia 743 74 999
Marital Status Married/living with partner 578 58 1000
Education Left school less than 15 years or no qualification 591 59 997
Health status &medicalconditions Self-rated health
very good/excellent 484 49 988
good 326 33
fair/poor 178 18
Hypertension 429 43 996
Low Blood Pressure 37 4 995
High Cholesterol 124 12 995
Myocardial infarction 114 11 996
Other heart problema 202 20 996
Stroke 58 6 996
Gout 67 7 996
Osteoporosis 68 7 996
Osteoarthritis 503 51 996
Other arthritis b 61 6 996
Emotional/psychiatric problems 94 9 996
Thyroid disease 37 4 996
Diabetes 64 6 996
Intestinal problems 197 20 996
Liver problems 14 1 995
Kidney or bladder problems 117 12 996
Chronic bronchitis 62 6 996
Emphysema 44 4 996
Asthma 89 9 996
Cataracts 186 19 994
Glaucoma 53 5 994
Anaemia 36 4 995
Migraine 54 5 996
Parkinsons 7 1 996
Problems feet or legs 360 36 995
Varicose veins 210 21 996
Eczema, dermatitis, psoriasis 114 11 996
Skin cancer 112 11 995
Other growths or cancer 33 3 996
*N - total number of data for each variable
aOther heart problems including angina and heart failure
b Other arthritis including rheumatoid and other specified types
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Most of the baseline MELSHA cohort reported they had
a regular doctor (in Australia this is the role of the Gen-
eral Practitioner (GP)) (95%). Similar proportions
reported seeing doctors older (49%) and younger (51%)
than 50 years and most were male doctors (87.5%).
Almost half the cohort (49%) reported that their blood
pressure had been checked within 1 month, 42% reported
that their vision had been checked within the last 12
months and 31% reported that their hearing had been
checked within 5 years. Twenty two percent of the cohort
reported that they had a hospital admission in the last 12
months. Most of the cohort reported that it had been less
than a month since they had visited their doctor (60%),
but more than 5 months since they had visited a pharma-
cist for advice (92%). Only 39% reported that their doctor
(GP) was aware of all the medications that they were tak-
ing.
Medication and Side effects
Of the baseline MELSHA cohort more than 76% reported
currently taking at least one prescribed medications. Self-
reported medication side effects were reported by
approximately 6.7% (67/1000) of the entire baseline
MELSHA cohort, and by 8.5% (65/761) of those on at
least one medication.
Univariate analysis
Factors associated with an increased risk of self-reported
medication side effects included: those whose doctors
were aware of their medications; those with poor to fair
self-reported health; and those with particular medical
conditions such as osteoporosis, emotional or psychiatric
problems, other arthritis including rheumatoid arthritis
and other specified types, intestinal problems such as an
ulcer or hiatus hernia, problems with feet and legs, liver
problems, and skin problems (eczema or dermatitis or
psoriasis). Mostly the risk of self-reported medication
side effects was increased 2-4-fold, but for those with
liver problems it was increased almost 6-fold. A similar
pattern was seen for the baseline MELSHA cohort (entire
population (n = 1000)) and those on at least one pre-
scribed medication (n = 761). See Table 2
Multivariate Analysis
The multivariate analysis predicted much of the risk of
medication side effects with a pseudo R2 of 0.442 (entire
population) and 0.478 (on at least one prescribed medica-
tion). There were no strong correlations between the
included risk factors as the largest partial correlations
were 0.2-0.4.
Factors associated with an increased risk of medication
side effects included: those with higher educational quali-
fications; attending younger doctors (< 50years); those
who had last visited a pharmacist for advice more than 5
months ago; those who reported their doctor's awareness
of their medications; those with particular medical condi-
tions such as diabetes, problems with their feet or legs,
skin problems (eczema, dermatitis or psoriasis) and cata-
racts. Mostly the risk was increased 2-4-fold. The greatest
increased risk of 5-8-fold was for those who reported
their doctor's awareness of their medications. The risk
was decreased by approximately 75% for those with
osteoarthritis and 65% for those with hypertension. A
similar pattern was seen for the baseline MELSHA cohort
(entire population (n = 536)) and those on at least one
medication (n = 509). See Table 3
In the multivariate analysis, data was complete for 54%
of the original cohort (n = 536) and 67% of those taking at
least one medication (n = 509). Missing data mostly
ranged from n = 1 to 7 and was greatest for participant
reported doctor's age n = 249 and participant use of strat-
egies for taking their medications n = 252. A comparison
of each individual risk factors and outcome by missing
status found that those with missing data tended to be in
better health and were less likely to be on any medica-
tions. A sensitivity analysis in which the two risk factors
with the greatest missing data participant reported doc-
tor's age and participant use of strategies for taking their
medications were excluded from the multivariate analysis
for both the entire cohort (n = 915) and those currently
taking medication (n = 710) gave a similar pattern of
results with the loss of recency of visit to the pharmacist
and addition of liver problems as seen in the univariate
analysis.
Discussion
The MELSHA study provided a unique opportunity to
examine the prevalence and possible risk factors for self-
reported medication side effects in a representative older
cohort living independently in the community. The prev-
alence of self-reported medication side effects in our
community based study was comparable with that seen in
other studies in the primary care and community setting
[2,3,24-28]. Our findings were consistent with prevalence
estimates from the more recent BEACH reports (from
General Practice based in a primary care community set-
ting) 9.3% in 2007-2008 and 10.4% in 2003-2004 [27,28].
However, there was a marked disparity with prevalence
estimates from hospital based studies through inpatients,
outpatients and ambulatory or emergency departments
of adults ranging in age from 18 to 75 years [8,16,29]. This
disparity may reflect differences in the settings including
selection, general health, use of medications and severity
of medication side effects, i.e. those hospitalised or
attending hospital are different to those living indepen-
dently in the community attending General Practice. In
addition, the disparity may also reflect differences in sur-
veillance practices such as definitions and methods for
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of exposures and outcomes.
The association with increased education of partici-
pants may reflect greater awareness and recognition of
medication side effects through general knowledge, dis-
cussion with their doctor or pharmacist, and reading the
product information. Recency of visiting the doctor
within a month was protective and having last received
advice from their pharmacist more than 5 months ago in
contrast to less than 5 months ago was associated with an
increased the risk of reporting medication side effects,
lending support for the role of education in facilitating
advice provided by doctors and pharmacists. In addition,
it was suggestive that advice on medications may be for-
gotten over time by an older cohort, so the importance of
regular monitoring and reinforcement by their doctors
and pharmacists. The important educative role of doctors
and pharmacists is further emphasised by another study
that found starting a new medication, cessation of a med-
ication or changes to prescribed and over the counter
(OTC) medications were associated with an increased
risk of medication side effects [14]. Therefore, doctors in
prescribing, and pharmacists in dispensing, have an
important role in detection and education.
The finding that an increased risk of medication side
effects was associated with those with a younger treating
doctor was more difficult to interpret as it was based on
participants' assessment and report of their doctor's age
and was associated with a high proportion of missing
data. It may be that doctors who were assessed as younger
tended to have less experience and make more therapeu-
tic mistakes including dosing and interactions as has been
suggested by another study [5]. Several studies have
found that a significant proportion of medication side
effects are preventable or ameliorable and include inade-
quate medical knowledge [13], flawed prescribing habits
including the issuing of inappropriate scripts [13,30,31]
and failure to monitor and review [13,30,31]. Alternately,
younger doctors may be more likely to use newer medica-
tions for which side effects are not fully known or they
may be more aware of medication side effects and/or bet-
ter educate and raise their patient's awareness.
The association of medication side effects with their
report of their doctor's awareness of their medications
may reflect the use of prescription medication, recency of
commencement of treatment, or use and monitoring of
medications with low therapeutic/toxicity thresholds.
Another possible explanation is that the prescribing doc-
tor is aware, but other doctors involved in the patient's
Table 2: Univariate Analysis Risk factors associated with self-reported medication side effects
Entire population
(n = 1000)
On medication
(n = 761)
OR 95% CI p OR 95% CI p
Recency doctor's visita 0.49 0.28 - 0.86 0.013 0.77 0.43 - 1.36 0.365
Doctor aware medicationb 3.11 2.44 - 3.96 < 0.0001 2.79 2.17 - 3.59 < 0.0001
Self reported health status c 2.00 1.46 - 2.75 < 0.0001 1.65 1.19 - 2.27 0.002
Hypertensiond 1.01 0.61 -1.67 0.971 0.63 0.37 - 1.05 0.075
Other heart problemsd , 1.89 1.10 - 3.24 0.021 1.48 0.85 - 2.55 0.163
Osteoporosisd 2.64 1.28 - 5.27 0.009 2.30 1.11 - 4.78 0.026
Emotional or psychiatric problemsd 2.80 1.49 - 5.27 0.001 2.51 1.30 - 4.86 0.001
Other arthritisd, f 3.92 1.97 - 7.79 < 0.0001 3.02 1.47 - 6.18 0.003
Intestinal problemd 2.27 1.33 - 3.86 0.002 1.91 1.11 - 3.30 0.020
Problems feet or legsd 4.28 2.51 - 7.31 < 0.0001 3.64 2.12 - 6.26 < 0.0001
Liver problemsd 5.83 1.78 - 19.11 0.004 6.45 1.84 - 22.63 0.004
Skin problemsd 1.97 1.04 - 3.74 0.037 1.90 0.99 - 3.64 0.053
a One month or more vs less than a month
b Yes vs No; Doctor's awareness related to usual doctor (General Practitioner)
c Very good to excellent vs poor to fair
d Yes vs No
eOther heart problems including angina and heart failure
f Other arthritis including rheumatoid and other specified types
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and interactions. Alternately, it may be that those who
report their doctor's awareness of their medications are
being monitored more frequently with greater opportu-
nity to detect medication side effects.
The association of medication side effects with diabetes
may reflect specific disease related issues around man-
agement including patient self management and collabo-
ration of treating health professionals as well as
therapeutic safety and/or greater opportunity for detec-
tion. In contrast for hypertension and osteoarthritis,
there was a protective association with medication side
effects. The difference in the findings for diabetes, hyper-
tension and osteoarthritis, all chronic conditions likely to
require regular follow up and review and hence offering
the opportunity for detection, suggests that the opportu-
nity for detection is an unlikely explanation. It may be
that the difference in their findings reflects greater thera-
peutic safety of medications used in hypertension and
osteoarthritis; more experience in their use by their usual
doctor as management of hypertension and osteoarthritis
is primarily managed by GPs in the primary care setting,
whereas diabetes care may be more fragmented with
management by specialists, GPs and other health profes-
sionals; or differences in patterns of associated co-mor-
bidities and other factors not measured.
Self-reported poor to fair health was associated with an
increased risk of medication side effects but it did not
persist in the multivariate analysis when specific medical
conditions were included. This association in the univari-
ate analysis may have reflected significant medical condi-
tions or alternately a focus on health including
medication side effects. An increased risk of medication
side effects was associated with particular medical condi-
tions that may mimick medication side effects such as
skin and liver problems; reflect changes to medication
metabolism such as with liver problems especially in
older patients; or use of medications with low therapeu-
tic/toxicity thresholds [4,13,18]. The number with liver
problems was too small to have sufficient power in the
reported multivariate analysis. Cataracts were associated
with an increased risk of medication side effects, possibly
reflecting ability to read labels and instructions and com-
ply. However, use of glasses or contacts was not associ-
ated with an increased risk, perhaps reflecting the use of a
strategy to cope with restricted vision and hence ability to
read labels. Other studies have found that medical condi-
tions and patient related factors including impaired eye
sight such as cataracts, hearing and cognition may
impinge on compliance [13,32].
A lack of association with age and gender was consis-
tent with the prevalence findings previously discussed;
with a study that reported minimal changes in pharmaco-
kinetics, pharmaco-dynamics and interactions with age
[32]; and studies that have found that increasing age may
be associated with increased numbers of medications
[18,30,33,34] and multiple co-morbidities [17,18,33,34]
which are independent risk factors. Those studies that
Table 3: Multivariate Analysis Risk factors associated with self-reported medication side effects*
Entire population
(n = 536)
On medication
(n = 509)
OR 95% CI p OR 95% CI p
Educationa 2.66 1.07 - 6.65 0.036 3.43 1.26 - 9.30 0.016
Doctor's ageb 2.38 1.01 - 5.56 0.048 2.70 1.08 - 7.14 0.035
Recency visit pharmacist for advicec 4.33 1.40 - 13.37 0.011 4.95 1.53 - 16.04 0.008
Doctor aware medicationd 5.44 3.03 - 9.77 < 0.0001 7.83 3.83 - 16.01 < 0.0001
Osteoarthritisd 0.24 0.09 - 0.65 0.005 0.23 0.08 - 0.68 0.008
Hypertensiond 0.41 0.16 - 1.04 0.059 0.34 0.12 - 0.93 0.035
Cataractsd 2.73 0.95 - 7.86 0.062 3.53 1.15 - 10.77 0.027
Diabetesd 3.01 0.82 - 11.06 0.096 4.00 0.98 - 16.82 0.053
Problems feet or legsd 3.87 1.57 - 9.53 0.003 3.97 1.51 - 10.46 0.005
Skin problemsd 3.99 1.39 - 11.44 0.010 3.98 1.31 - 12.09 0.015
*Entire population pseudo R^2 = 0.442 (Nagelkerke); On medication, R^2 = 0.478 (Nagelkerke).
a Completion high school or additional qualifications vs lower than high school education;
b Aged younger than 50 years vs 50 years and older;
c Five months or more vs less than five months;
d Yes vs No
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side effects [6,30,33,34], have been in young to middle
aged patient groups [29] perhaps suggestive of an age
threshold. As genetics may account for 20-95% variability
in medication side effects [35], those who are long-lived
may have favourable/protective genetics. Likewise, the
lack of association with gender was consistent with those
of another study in an older cohort with a mean age of
81.4 years in which no gender association was observed
[34]. Again, those studies that have found an association
with female gender [31,34,36] have been in young to mid-
dle aged patient cohorts [29].
There were several potential limitations of the study
findings. The MELSHA data were collected in 1994 and
may not reflect the current situation. However, the preva-
lence of self-reported medication side effects in the
MELSHA cohort in the community in 1994 was/is similar
to more recent and contemporary prevalence estimates of
medication side effects in the BEACH reports. We have
not focused on specific medications for which indications
and use may have changed. Our analysis focused on inde-
pendent stable risk factors including socio-demograph-
ics, health status and medical conditions, and health
service factors. For example the measurement of age or
classification of gender or marital status or medical con-
ditions or definitions and scaling of self reported health
status would be consistent now with 1994. The examined
risk factors predicted a significant percentage (45%) of
the risk of self-reported medication side effects.
The reliance on recall and self report may have poten-
tially introduced systematic error or bias affecting the
internal validity of the study findings as well as random
error affecting the reliability and precision of the study
findings. The internal validity of the study may have been
affected by information bias due to the reliance on recall
and self report. Such a possibility can not be definitively
excluded. However, previous studies have found good
levels of agreement between recall and self report of
medication usage with pharmaceutical claims data as well
as home visit verification [37,38]. It is possible that the
prevalence of medication side effects may have been
underestimated as only more recent or severe or persis-
tent medication side effects may be recalled. However,
our findings with respect to the prevalence of medication
side effects appeared to be consistent with those from
other studies including the more contemporary studies in
the ongoing BEACH report as discussed previously
[27,28]. It is also possible that those with medication side
effects may have reflected more on possible associated
risk factors. However, socio-demographic factors would
not be affected and those of medical conditions and med-
ications were verified independently by the interviewer.
The survey was administered by a trained interviewer
and so there was the opportunity for clarification and
probing. In addition, the interviewer provided a standard
written list of medical conditions and checked medica-
tions, providing some additional verification to self-
report alone with respect to medical conditions and med-
ications. Therefore, although recall bias is a possibility, it
would seem an unlikely explanation for our findings. In
addition, the effect of potential bias from potential con-
founders has been adjusted for in the multivariate analy-
sis. However, it is not possible to adjust for unknown
confounders or confounders on which data were not col-
lected.
It has been suggested that self report of medication side
effects may be less accurate and less reliable than chart
review that is possible in clinical settings [32,34]. A lack
of reliability in the use of self-report, may result in lack of
precision and loss of power to detect an effect/associa-
tion. However, a study of older Australians' medication
use that examined self report by phone compared with a
home visit and inventory found self report was accurate
(high agreement as measured by kappa) for all prescribed
medication categories [37].
Other potential issues were missing data and the small
numbers with medication side effects. Missing data may
have reduced the power to detect an association or intro-
duced potential bias. However, sensitivity analyses
around missing data found a similar pattern of results.
The small numbers with medication side effects may have
meant that the study had insufficient power to examine
risk factors of smaller magnitude of effect or rarer/less
common risk factors, but we have only commented on
those associations detected by this study. The small num-
bers also meant that some categories had to be collapsed
which may have further affected the findings, although
this was limited by an apriori approach based on similar-
ity and logic.
Overall, given the random sampling and selection of
the MELSHA cohort, the findings are likely to be general-
isable to older people living independently in the commu-
nity. It is important to reflect on strategies to address
some of the potential risk factors identified. From a
review and framework proposed by the National Pre-
scribing Service (NPS) [39] in conjunction with our find-
ings, key approaches would include: targeting specific
diseases identified by our study; addressing the awareness
and knowledge of health professionals in particular doc-
tors and pharmacists as well as patients; and communica-
tion between health professionals and between health
professionals and patients [39].
In targeting specific diseases diabetes would be a useful
starting point, and other diseases that may be considered
include osteoporosis, heart problems such as arrhythmias
and cardiac failure, emotional or psychiatric conditions
and other arthritis. In addition to existing strategies for
improved diabetes management, it may be that the man-
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insights into disease focused management strategies to
minimize medication side effects. As well, the need for
additional care in using medications in those with liver
problems needs emphasising.
Greater awareness and knowledge of health profession-
als including doctors and pharmacists as well as patients
is also important. Further education during medical
training and scaffolding in the workplace may support
doctors in developing safe rational prescribing practices
that minimize medication side effects. Specific education
strategies for health professionals in particular doctors
and pharmacists may include integration into undergrad-
uate curriculae as well as post graduate/professional
ongoing continuing medical education programs; sup-
portive systems such as provision of information through
professional colleges, support software, and emphasis on
continuity of care over fragmentation; and quality control
through participation in audits. In particular areas need-
ing highlighting include the need for increased awareness
and follow up and review in relation to the timing of med-
ication side effects such as when introducing new medi-
cations and in particular for newly licensed medications
as well as over the counter medications; similarly with the
cessation and changing of medications; increased aware-
ness of the range of presentations of medication side
effects and the need to consider as a differential diagno-
sis; importance of participation in national surveillance
and reporting systems for adverse drug reactions to
increase the shared information available and the ability
to detect a signal earlier. Improved health education of
patients may enable early recognition and prevention of
potential medication side effects.
Communication between health professionals includ-
ing between GPs and specialist as well as pharmacists and
other health professionals and with patients may facilitate
management as well as surveillance and detection. Given
the pivotal role of treating doctors and pharmacists in
providing patient education and monitoring/surveillance
of medication side effects, factors such as continuity or
systems for information sharing may facilitate this role
for doctors and pharmacists as well as other health pro-
fessionals. As suggested by the NPS e-health may be one
way in which such communication and information shar-
ing may occur.
Finally in recognising and better managing medication
side effects, it is important that medication side effects
are not simply attributed to increased age. This requires
increased awareness and consideration of other potential
risk factors in older people, to better prevent and manage
medication side effects. Prevention may require greater
use of strategies by patients and health professionals to
address potential sensory, physical and cognitive deficits
with aging that may be associated with compliance prob-
lems: ongoing supervision and use of dosette boxes; regu-
lar medication reviews; provision of readily understood
written instructions on medications including how to
take and potential side effects in large readily read print;
establishment of hotlines for patients to obtain additional
information this would offer the potential to provide for
those with hearing or language difficulties.
Conclusion
The findings from the MELSHA cohort are generalisable
to older people living independently in the community.
Identified risk factors provide insights and directions for
strategies to address the important issue of reducing
medication side effects in older people. In the future, it
will be important to develop education programs and
policy that improve the level of awareness of medication
side effects and provide greater opportunity for preven-
tion and early management.
Appendix Summarised Extract of Questions from 
Survey Instrument
1. Interviewer administered survey
Background Socio-demographic information
"Record gender (do not ask): Male, Female"
"How old are you (age in years"
"In what country were you born: Australia, Britain or
Ireland, Italy, Greece or Cyprus, Yugoslavia, Germany,
Netherlands, New Zealand, Poland, South East Asia,
Other European, Other(specify), Don't know/refused)"
"Which of these best describes your highest qualifica-
tion: Bachelor degree or higher, Trade/apprenticeship,
certificate/diploma, Other (specify), Don't know/
refused."
"Ask only if necessary: Are you now married (Probe as
needed to code further): Now married, living with part-
ner, widowed, divorced, separated, never been married,
other (specify), don't know/refused."
Health conditions: Health status & Self-reported medical 
conditions
Health status "Now I have some questions about your
health. Would you say that for someone of your age your
own health, in general, is (Read Out): Excellent, Very
Good, Good, Fair, Poor, Don't know/refused."
Medical conditions "Has a doctor ever told you that you
have (Read out each condition ...........code as Yes or No):
blood pressure, heart attack or myocardial infarct, other
heart problems, stroke, osteoporosis or brittle bones,
emotional, nervous or psychiatric problems."
"Now I want to show you a list of other medical condi-
tions. Please tell me which of these medical conditions
you have now? ( Show card with list of medical conditions
..........code as Yes or No): high cholesterol, low blood pres-
sure, gout, diabetes or high blood sugar, osteoarthritis
(arthritis unspecified), other types of arthritis ( including
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Page 10 of 11rheumatoid and other specified types), intestinal prob-
lems (such as ulcer or hernia), chronic bronchitis, emphy-
sema, asthma, problems with feet and legs, cataracts,
glaucoma, liver trouble or jaundice, kidney or bladder
problems, prostate trouble (men only), anaemia, Parkin-
son's disease, migraine, eczema or dermatitis or psoriasis,
skin cancer, other growths or cancer, shingles, varicose
veins, and thyroid disease".
Note in the analysis prostate problems was omitted as
gender specific and shingles was omitted as short term
episodic.
Use of aids "Next I want to ask you about aids or equip-
ment you may use. Do you currently use any aids or
equipment on this card? (Read out each item if neces-
sary..............code 1 for used and 0 if not used):....hearing
aid, ...., glasses or contact lenses?"
Health services
"Have you been admitted to Hospital in the last 12
months: Yes, No, Don't know/refused."
"Using this card ( show card.....). Please tell me about
how long is it since you've: (Read out below: Codes-
within a month, 1-5 months, 6-11 months, 1-2 years, 3-4
years, 5 or more years, never): seen a doctor,
....................been to a chemist for advice?"
"About how long is it since you've (Read out) use codes
from previous card: Codes-within a month, 1-5 months,
6-11 months, 1-2 years, 3-4 years, 5 or more years, never):
......................., Had your blood pressure
checked?,................."
Medications
"The next few questions are about medicines. Could you
please show me any medications prescribed by a doctor
that you have taken or were supposed to take in the last 2
weeks.................... Check the prescribed medicines against
the medications list............., recorded as No or Yes".
"Does the respondent have any medicines ................pre-
scribed by a doctor that he/she has taken or was sup-
posed to take in the last two weeks? Yes, No, Don't know/
refused"
"Was this prescribed by your doctor? Circle "1" if
answer is yes."
"Does your doctor know you use this medication? Cir-
cle "1" if answer is yes."
"Do you have any side effects from this medication?
Circle "1" if answer is yes".
"Do you do anything to make sure you take the right
amount of medicine at the right time? Code Yes, No,
Don't know/refused."
2. Interviewer Observations
Observations on gender, ability to speak English, physical
difficulties including hearing impairment, crippled hands
or legs, understanding of questions, difficulty remember-
ing and accuracy of responses
3. Self completion survey
Do you have a regular doctor?
About how old is your doctor (age in years)?
Is your doctor a man or woman?
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